Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

DEFA14A

SEC Filing Details

Document Details

Filing Date
Apr 30, 2018
Document Date
Apr 30, 2018
Form Description
Additional proxy soliciting materials - definitive
Filing Group
Proxy Filings
Company
Stemline Therapeutics
Issuer
STEMLINE THERAPEUTICS INC


Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved